5 alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
Stoner
E
E
Merck & Co., Inc., Rahway, New Jersey 07065.
D058891:5-alpha Reductase Inhibitors; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017326:Clinical Trials, Phase III as Topic; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D058891:5-alpha Reductase Inhibitors; D018120:Finasteride